NASDAQ: TELO
Telomir Pharmaceuticals Inc Stock Ownership - Who owns Telomir Pharmaceuticals?

Insider buying vs selling

Have Telomir Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Erez AminovCEO and Chairman2026-04-227,319,710$1.37
$10.03MBuy

1 of 1

TELO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TELO insiders and whales buy or sell their stock.

TELO Shareholders

What type of owners hold Telomir Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Erez Aminov10.64%7,319,710$9.08MInsider
Mira Pharmaceuticals Inc5.12%3,521,127$4.37MInsider
Shore Trust Bay4.79%3,292,696$4.08MInsider
Vanguard Capital Management LLC1.45%995,373$1.23MInstitution
Christopher C. Chapman Jr.1.42%975,610$1.21MInsider
Craig Eagle0.71%487,805$604.88kInsider
Blackrock Inc0.42%289,198$358.61kInstitution
Geode Capital Management LLC0.36%249,086$308.87kInstitution
Vanguard Fiduciary Trust Co0.20%135,541$168.07kInstitution
Millennium Management LLC0.19%129,060$160.03kInstitution

1 of 3

TELO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TELO3.26%23.07%Net BuyingNet Buying
HRTX55.61%44.39%Net BuyingNet Selling
RANI34.48%32.99%Net Selling
ACRV37.93%35.92%Net BuyingNet Buying
CGTX23.93%30.49%Net SellingNet Selling

Telomir Pharmaceuticals Stock Ownership FAQ

Who owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals (NASDAQ: TELO) is owned by 3.26% institutional shareholders, 23.07% Telomir Pharmaceuticals insiders, and 73.67% retail investors. Erez Aminov is the largest individual Telomir Pharmaceuticals shareholder, owning 7.32M shares representing 10.64% of the company. Erez Aminov's Telomir Pharmaceuticals shares are currently valued at $8.86M.

If you're new to stock investing, here's how to buy Telomir Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.